Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514

被引：0
|
作者：
Bahleda, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Soria, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Harbison, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Park, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Felip, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hanna, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Laurie, S. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Armand, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Shepherd, F. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Herbst, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Valle Hebron Univ Hosp, Barcelona, Spain
[5] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[6] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[7] Inst Claudius Regaud, Toulouse, France
[8] Univ Toronto, Toronto, ON, Canada
[9] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8098
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Genomic landscape of patients with non-small cell lung cancer (NSCLC)
    Singh, Neeraj Kumar
    Saini, Kamal S.
    Chakkrapani, Sangavai
    Severson, Eric
    Nagaraj, Nahush
    Ramkissoon, Shakti
    Chico, Isagani
    Aguilo, Ariel
    George, Rohini
    Vidal, Laura
    Agrawal, Smita
    CANCER RESEARCH, 2023, 83 (07)
  • [42] The generation of tumor reactive lymphocytes in non-small cell lung cancer (NSCLC)
    Yannelli, JR
    Wroblewski, JM
    FASEB JOURNAL, 2002, 16 (04): : A667 - A667
  • [43] VALIDATION OF GENE EXPRESSION BIOMARKER PANELS IN NON-SMALL CELL LUNG CANCER
    Dong, Jie
    Huebner, Marianne
    Azodo, Ijeoma
    Tomaszek, Sandra C.
    Sun, Zhifu
    Kosari, Farhad
    Wang, Lifeng
    Jen, Jin
    Aubry, Marie Christine
    Yang, Ping
    Vasmatzis, George
    Wigle, Dennis A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S279 - S279
  • [44] Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
    Jung, Young Ju
    Oh, In-Jae
    Kim, Youndong
    Jung, Jong Ha
    Seok, Minkyoung
    Lee, Woochang
    Park, Cheol Kyu
    Lim, Jung-Hwan
    Kim, Young-Chul
    Kim, Woo-Sung
    Choi, Chang-Min
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (53)
  • [45] Identification and validation of MTAP as a potential biomarker for non-small cell lung cancer
    Zhang, K. T.
    Li, B. Y.
    Qian, X. H.
    Ying, W. T.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S59 - S59
  • [46] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Nicolazzo, Chiara
    Raimondi, Cristina
    Mancini, MariaLaura
    Caponnetto, Salvatore
    Gradilone, Angela
    Gandini, Orietta
    Mastromartino, Maria
    del Bene, Gabriella
    Prete, Alessandra
    Longo, Flavia
    Cortesi, Enrico
    Gazzaniga, Paola
    SCIENTIFIC REPORTS, 2016, 6
  • [47] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Chiara Nicolazzo
    Cristina Raimondi
    MariaLaura Mancini
    Salvatore Caponnetto
    Angela Gradilone
    Orietta Gandini
    Maria Mastromartino
    Gabriella del Bene
    Alessandra Prete
    Flavia Longo
    Enrico Cortesi
    Paola Gazzaniga
    Scientific Reports, 6
  • [48] Longitudinal evaluation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
    Ikeda, Mio
    Koh, Yasuhiro
    Teraoka, Shunsuke
    Sato, Koichi
    Tokudome, Nahomi
    Hayata, Atsushi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Akamatsu, Keiichiro
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 83 - 83
  • [49] Longitudinal investigation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
    Koh, Yasuhiro
    Ikeda, Mio
    Teraoka, Shunsuke
    Sato, Koichi
    Tokudome, Nahomi
    Hayata, Atsushi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Akamatsu, Keiichiro
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Development of a radiogenomic biomarker for tumor characterization and prognosis in Non-Small Cell Lung Cancer patients
    Singh, Apurva
    Wang, Zhuoyang
    Katz, Sharyn
    Yousefi, Bardia
    Kontos, Despina
    MEDICAL IMAGING 2021: COMPUTER-AIDED DIAGNOSIS, 2021, 11597
12345